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Abstract
Background: Cervical cancer is the fourth most common cancer among women across the world. Recent studies have
shown that cervical cancer is not only caused by persistent infection of human papillomavirus (HPV), but sexually
transmitted infections (STIs) also play a role in the pathogenesis of abnormal cervical cells. STIs frequently occur with
no specific symptoms, such as the infections caused by Chlamydia trachomatis and Mycoplasma hominis.
Asymptomatic STIs could lead to persistent infection. Persistent infections caused by STIs have been hypothesised to
increase the access of HPV into the deeper cervical tissue and cause cervical cell abnormalities. Therefore, we
conducted this study to assess the association between C. trachomatis and M. hominis infections and abnormal cervical
cells. Methods: A cross-sectional study was performed on 58 outpatients at the Department of Obstetrics and
Gynecology, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Abnormal cervical cells were detected by a liquidbased cytology Pap smear, and bacterial identification was done by conducting conventional duplex polymerase chain
reaction (PCR). Results: 58 patients, 14 (24.1%) showed abnormal cervical cells, whereas 44 (75.9%) patients showed
normal cervical cells. The conventional duplex PCR demonstrated a positive result for C. trachomatis and M. hominis
bacterial infections in only 1 (7.1%) and 2 (14.3%) patients with abnormal cervical cells, respectively. The statistical
analysis revealed no significant association between the bacterial infections and the abnormal cervical cytology in the
patients (p > 0.05). Conclusions: Infections caused by C. trachomatis and/or M. hominis were not associated with
abnormal cervical cells.
Keywords: cervical cancer, Chlamydia trachomatis, human papillomavirus (HPV), Mycoplasma hominis, sexually
transmitted infections

Introduction

cervical cancer.2,3 HPV was detected in 90% of cervical
cancer cases, with the majority being HPV-16 and -18
types.2,3 Cervical cancer, which is initiated by precancerous lesions, can be detected using a liquid-based
cytology (LBC) Pap smear.4 These pre-cancerous lesions
are caused by persistent HPV infections, and they are also
involved in other risk factors, such as other sexually transmitted infections (STIs).5,6 STIs have been hypothesised
as risk factors for pre-cancerous cervical lesions, because
these infections could cause persistent infections with no
specific symptoms. These persistent infections can
increase the access of HPV into the deeper cervical
tissue.5,6

Cervical cancer is the fourth most common malignancy
among women across the world, and it is the second
leading cause of female cancer in Indonesia.1 Reports on
human papillomavirus (HPV) and related diseases from
Indonesia have shown that the incidence of cervical
cancer is 20.928 cases/year with 9.498 deaths/year.1
These data indicate that the morbidity and the mortality
of cervical cancer are high, wherein the mortality rate is
about 50% of the morbidity rate each year.
Persistent infections caused by HPV have been reported
to be the primary aetiology of pre-cancerous lesions and
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Among STIs, several studies have reported that infections
caused by C. trachomatis and M. hominis play an
important role in the persistence of HPV infection,
leading to cervical cancer.5–7 C. trachomatis infection
could inhibit the apoptosis of infected cells,5,8 whereas
M. hominis infection could suppress the cell-mediated
immunity.9,10 These mechanisms render the infected
cervical cells to become more susceptible to HPV infection
and lead to HPV persistence.9 A study in Korea reported
that C. trachomatis infections were significantly higher
in abnormal cervical cells than in normal cells.6 Another
study from Argentina demonstrated that C. trachomatis
infections were higher in HPV-positive (34.2%) than in
HPV-negative subjects (19%).5 M. hominis was detected
in 5.33% of abnormal cervical cells.9 Yet another study
from Nigeria showed a significant association between
M. hominis and persistent HPV.10 To our knowledge,
there is no report about the roles of C. trachomatis and
M. hominis infections as risk factors for abnormal
cervical cells in patients from Indonesia. Therefore, we
conducted this cross-sectional study to determine the
association between C. trachomatis and M. hominis
infections and abnormal cervical cells.

Methods
Study Population. A total of 58 female outpatients
attending the Colposcopy Outpatient Clinic, Department
of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo
Hospital (RSCM), Jakarta, Indonesia, during June to
October 2016, were included in this cross-sectional study.
The participants were aged 20–67 years and were
sexually active. Patients who were pregnant and received
antibiotics during the past 4 weeks were excluded. This
study was approved by the Ethics Committee of the

Faculty of Medicine, Universitas Indonesia, with no:
98/UN2.F1/ETIK/2016, and all subjects provided the
written informed consent for participation in the study.
Specimens. Samples of cervical swabs collected by
specialist doctors were immediately inserted into LBC
vials (LiquiPrep, LGM International Inc, USA). The
samples were aliquoted into two tubes, each 5 mL, for
LBC Pap smear and polymerase chain reaction (PCR).
Transportation and storage of the samples were maintained at 4 °C, and the samples were processed within
not more than 2 days from the day of collection.
LBC Pap Smear. LBC Pap smears were performed
according to the manufacturer’s protocol (LiquiPrep,
LGM International Inc, USA) under the supervision of a
pathologist. Normal and abnormal cells were classified
according to the Bethesda classification system as follows:
negative for intra-epithelial lesions or malignancy (NILM),
atypical squamous cells of undetermined significance
(ASCUS), atypical squamous cells-cannot exclude HSIL
(ASCH), low-grade squamous intra-epithelial lesion
(LSIL) and high-grade squamous intra-epithelial lesion
(HSIL).11 The ASCUS, ASCH, LSIL and HSIL were
classified as results depicting an abnormal cervical
cytology.
DNA Extraction. One millilitre of samples was
centrifuged at 13,000 rpm for 30 min. The pellet was
suspended in 200 µL of phosphate-buffered saline (PBS)
and extracted in accordance with the manufacturer’s
protocol (High Pure PCR Template Preparation Kit,
Roche, Germany) using 50 µL of the final elute. Sample
collection and DNA extraction were validated by PCR
conducted using standard β-globin primers (Figure 1).
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Figure 1. Human β-Globin (266 bp) Detection Using Conventional PCR. M: Marker; P: Positive Control; N: Negative
Control; S1–S7: Samples; bp: Base Pair
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PCR for Detecting C. trachomatis and M. Hominis. C.
trachomatis and M. hominis were detected by conducting
conventional duplex PCR using the following primers
reported by Dhawan et al.12 and Pascual et al.13: C.
trachomatis with a product size of 71 bp (Ctr forward
5ʹ-CATGAAAACTCGTTCCGAAATAGAA-3ʹ and Ctr
reverse 5ʹ-TCAGAGCTTTACCTAACAACGCATA-3ʹ)
and M. hominis with a product size of 101 bp (Mh
forward 5ʹ-TTTGGTCAAGTCCTGCAACGA-3ʹ and
Mh reverse 5ʹ-CCCCACCTTCCTCCCAGTTA-3ʹ). The
PCR was performed using a total volume of 20 µL
containing 10× PCR buffer, 1.2 mM MgCl2, 0.2 mM
dNTP mix, 5× Q solution, 0.05 µM primer mix of M.
hominis, 0.45 µM primer Ctr_F, 0.15 µM primer Ctr_R,
1.25 U of the enzyme Taq polymerase (HotStarTaq DNA
Polymerase, Qiagen) and 4 µL of DNA sample. Thermal
cycles of PCR were performed using a Biosystems
GeneAmp PCR System 2700 (Applied Biosystems, USA)
at 95 °C for 15 min, with 40 amplification cycles at 94
°C for 30 s, 60 °C for 30 s and 72 °C for 30 s. The final
elongation step was performed at 72 °C for 7 min.
M

N

P

S1

S2

The PCR products were analysed on 9% polyacrylamide
gel electrophoresis (PAGE), and the DNA bands were
documented by UV transillumination (GelDocTM XR,
Biorad).
Statistical Analysis. The statistical analysis was performed
by Fisher’s exact test using the IBM SPSS (version 20)
software package (IBM Corp., USA). Data were reported
as numbers (percentages) with 95% convidence intervals.
The results were considered to be significant when p ≤
0.05.

Results
In total, 58 patients who participated in this study, 44
(75.9%) and 14 (24.1%) patients were diagnosed with
normal (NILM) and abnormal cervical cytology results,
respectively. Of the 14 patients with an abnormal cervical
cytology, 6 (12.5%) had ASCUS, 4 (8.3%) had ASCH,
1 (2.1%) had LSIL and 3 (6.3%) patients had HSIL.
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Figure 2. C. trachomatis (71 bp) and M. hominis (10 bp) Detection Using Conventional Duplex PCR. M: Marker; P: Positive
Control; N: Negative Control; S1–S7: Samples; bp: base pair
Table 1. Cytopathological Results of The Screening of Indonesian Women with and Without C. trachomatis and M. hominis
Infections
Negative cytology (NILM)
n (%)

Abnormal cytology
n (%)

C. trachomatis
Positive
Negative

0 (0)
44 (100)

1 (7.1)
13 (92.9)

0.241

M. hominis
Positive
Negative

3 (6.8)
41 (93.2)

2 (14.3)
12 (85.7)

0.348

Results

p*

NILM: negative for intra-epithelial lesion or malignancy. Abnormal cervical cytology includes ASCUS, ASCH, LSIL and HSIL. ASCUS: atypical
squamous cells of undetermined significance. ASCH: atypical squamous cells-cannot exclude HSIL. LSIL: low-grade squamous intra-epithelial
lesion. HSIL: high-grade squamous intra-epithelial lesion. n: number of patients.*: The comparison between cases with positive and negative test
results according to Fisher’s exact test.

Makara J. Health Res.

April 2018 | Vol. 22 | No. 1

56 Mardhia, et al.

The conventional duplex PCR results (Figure 2) revealed
the presence of C. trachomatis in 1 of the 14 patients with
an abnormal cervical cytology, whereas C. trachomatis
infection was not detected in the 44 patients with NILM
results (Table 1). M. hominis was detected in 2 of the 14
patients with an abnormal cervical cytology and in 3 of
the 44 patients with NILM results. As shown in Table 1,
no significant association was found between C.
trachomatis and/or M. hominis infection and abnormal
cervical cytology, with the p values being 0.241 and
0.348, respectively.

Discussion
HPV, especially the high-risk genotypes, is known as an
aetiological agent causing cervical cancer disease. However, the changes from normal to cancerous cervical cells
are influenced by several risk factors.2,5,6 One of the risk
factors is sexually transmitted bacterial infections,
including the infections causing by C. trachomatis and
M. hominis.5,6 The specific role of bacterial infections in
regulating the changes in cervical cells of HPV-infected
women has not yet been delineated. A possible explanation is that the bacterial infections may increase
the susceptibility of women to HPV infection through
changes in cervical cells leading to a higher susceptibility
to HPV infection.5,14 Several studies have demonstrated
the association between bacterial infections and the
development of abnormal cervical cells.5,6,14,15
C. trachomatis has been reported to be the topmost
aetiological agent causing STIs across the world, with
approximately 89 million cases/year.5 This bacterial
infection has also been reported to play an important
role in the development of abnormal cervical cells.
These infections might lead to chronic and persistent
infections and inflammation, leading to the inhibition of
cell apoptosis and metaplasia in cervical squamous
cells, thereby rendering the cells susceptible to HPV
infection.5,16 Moreover, the persistent infection might
lead the persistence of HPV, which is an indicator for
the development of cervical cancer.17
In Indonesia, the prevalence of C. trachomatis infection
has been reported to be about 7.9%.18 However, there is
no information regarding the association between C.
trachomatis infection and abnormal cervical cells. In the
present study, we found no significant association
between C. trachomatis and abnormal cervical cytology,
with the p value being 0.241. This result was consistent
with that reported by de Castro-Sobrinho et al.,19 with
the p value being 0.2 in their study. In contrast, another
study reported that abnormal cervical cells showed a
higher percentage of positive C. trachomatis.6 This
difference in results might be caused due to several
factors, in particular, the local customs, the behaviour
and the risk exposure of particular women.20
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Besides C. trachomatis, we also investigated the role of
M. hominis as a risk factor for the development of
abnormal cervical cells. The bacterium can be found as
a commensal agent in healthy women, but it can be a
harmful agent in sexually active women.9,21 Several
studies have demonstrated the association between M.
hominis infection and cervical problems.21–23 Indeed, a
study reported that M. hominis infection could suppress
the cell-mediated immunity, an important protective
mechanism against HPV infection.9,10 However, in this
study, we found no such association between M.
hominis infection and abnormal cervical cells (p =
0.348). Although there was no statistically significant
association, the percentage of M. hominis in patients
with an abnormal cervical cytology was higher (14.3%)
than that in patients with a normal cervical cytology
(7%). Similarly, other studies conducted by Farag et
al.,9 Choi et al.6 and Kim et al.24 also showed no
significant association between M. hominis and abnormal
cervical cytology.
A limitation of this study is that we did not analyse the
association between C. trachomatis and/or M. hominis
and infections caused by HPV, an aetiological virus
causing cervical cancer disease. In addition to these
bacterial infections, it is necessary to include STIs
caused by other bacteria such as Ureaplasma urealyticum
and U. parvum in future studies.
Moreover, further research using a larger population
must be conducted. The status of other STI-causing
agents and HPV infection may be used as a research
variable. The findings of this study may be used as
information to improve the quality of treatment of
patients with pre-cancerous cervical lesions, by including
the microbiological examination of women with an
abnormal cervical cytology.

Conclusions
This study demonstrated that C. trachomatis and/or M.
hominis infections have no significant association with
an abnormal cervical cytology. However, it is known
that HPV infections alone do not influence the changes
from normal to abnormal cervical cells. There are
several risk factors influencing the cellular changes, one
of them being sexually transmitted bacterial infections.
Therefore, it is necessary to address other sexually
transmitted bacterial infections besides C. trachomatis
and M. hominis in future studies.
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